117358-51-7 Usage
General Description
3,5-Difluorotoluene is a chemical compound that consists of a toluene molecule with two fluorine atoms attached at the 3 and 5 positions on the benzene ring. It is a colorless liquid with a strong odor and is primarily used as an intermediate in the production of pharmaceuticals, agrochemicals, and other organic compounds. 3,5-Difluorotoluene is also used as a solvent and in the manufacture of dyes, resins, and other chemicals. It is flammable and may release toxic fumes when heated, but it is not considered to be highly toxic to humans or the environment. However, proper handling and storage of this chemical are essential to prevent any adverse effects on human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 117358-51-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,3,5 and 8 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 117358-51:
(8*1)+(7*1)+(6*7)+(5*3)+(4*5)+(3*8)+(2*5)+(1*1)=127
127 % 10 = 7
So 117358-51-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H6F2/c1-5-2-6(8)4-7(9)3-5/h2-4H,1H3
117358-51-7Relevant articles and documents
P38 KINASE INHIBITING AGENTS
-
Page/Page column 32, (2010/11/18)
Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof: Formula (I); are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of asthma, COPD, ARDS, rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.
Isothiazole derivatives useful as anticancer agents
-
, (2008/06/13)
The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein X1, R1, R2and R3are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods treating hyperproliferative disorders in mammals by administering the above compounds.